Cargando…

Flucelvax Tetra: a surface antigen, inactivated, influenza vaccine prepared in cell cultures

Detalles Bibliográficos
Autores principales:	Bühler, Silja, Ramharter, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350724/ https://www.ncbi.nlm.nih.gov/pubmed/30792907 http://dx.doi.org/10.1136/esmoopen-2018-000481

Ejemplares similares

Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax(®) Tetra/Flucelvax Quadrivalent(®)): A Review in the Prevention of Influenza
por: Lamb, Yvette N.
Publicado: (2019)

Correction to: Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax(®) Tetra/Flucelvax Quadrivalent(®)): A Review in the Prevention of Influenza
por: Lamb, Yvette N.
Publicado: (2019)

LB15. Vaccine Effectiveness of Flucelvax Relative to Inactivated Influenza Vaccine During the 2017–18 Influenza Season in Northern California
por: Klein, Nicola P, et al.
Publicado: (2018)

Influenza virus inactivated vaccine for pig: virus culture in embryonated egg allantoin and preparation
Publicado: (1987)

L’Health Technology Assessment come strumento value-based per la valutazione delle tecnologie sanitarie. Reassessment del vaccino antinfluenzale quadrivalente da coltura cellulare: Flucelvax Tetra(®) 2.0
por: CALABRÒ, GIOVANNA ELISA, et al.
Publicado: (2023)

Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season
por: Klein, Nicola P., et al.
Publicado: (2020)

Large-Scale Preparation of UV-Inactivated SARS Coronavirus Virions for Vaccine Antigen
por: Tsunetsugu-Yokota, Yasuko
Publicado: (2007)

Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine
por: Bahnemann, Hans G.
Publicado: (1990)

Avian Influenza: preparation not panic
por: Richards, Guy
Publicado: (2006)

Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults
por: Montomoli, Emanuele, et al.
Publicado: (2018)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
por: Sridhar, Saranya, et al.
Publicado: (2015)

High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors
por: Becker, Debbie L., et al.
Publicado: (2016)

2743. Safety of Recombinant Influenza Vaccine Compared with Inactivated Influenza Vaccine in Adults
por: Hansen, John, et al.
Publicado: (2019)

Preparing for the vaccine
Publicado: (2020)

Vaccines for Influenza
por: Tsilibary, Effie-Photini, et al.
Publicado: (2021)

Preparation and evaluation of goose reovirus inactivated vaccine
por: Niu, Xiaoyu, et al.
Publicado: (2017)

1059 Expanded immunogenicity of high-dose inactivated influenza vaccine compared to standard-dose inactivated influenza vaccine in older adults
por: Diazgranados, Carlos, et al.
Publicado: (2014)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine
por: Wilder-Smith, Annelies, et al.
Publicado: (2021)

Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study
por: Hansen, John, et al.
Publicado: (2020)

THE ANTIGENIC POTENCY OF EPIDEMIC INFLUENZA VIRUS FOLLOWING INACTIVATION BY ULTRAVIOLET RADIATION
por: Salk, Jonas E., et al.
Publicado: (1940)

Influenza Virus and Vaccination
por: Nogales, Aitor, et al.
Publicado: (2020)

Standardisation of inactivated influenza vaccines—Learning from history
por: Wood, John M., et al.
Publicado: (2018)

An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection
por: Ni, Yawei, et al.
Publicado: (2018)

Update of inactivated equine influenza vaccine strain in Japan
por: GAMOH, Koichiro, et al.
Publicado: (2017)

Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production
por: Herrera-Rodriguez, José, et al.
Publicado: (2019)

Challenges in the development of T-cell–based universal influenza vaccines
por: Kang, Jung-Ok, et al.
Publicado: (2017)

Exploring the Potential of T-Cells for a Universal Influenza Vaccine
por: Vijayanand, Sharon, et al.
Publicado: (2020)

Balanced Cellular and Humoral Immune Responses Targeting Multiple Antigens in Adults Receiving a Quadrivalent Inactivated Influenza Vaccine
por: Yu, Esther Dawen, et al.
Publicado: (2021)

A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccines
por: Schmeisser, Falko, et al.
Publicado: (2016)

Innate Responses Induced by Whole Inactivated Virus or Subunit Influenza Vaccines in Cultured Dendritic Cells Correlate with Immune Responses In Vivo
por: Stoel, Maaike, et al.
Publicado: (2015)

Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018–2019 Influenza Season in the United States
por: Boikos, Constantina, et al.
Publicado: (2021)

An orderly inactivation of intracellular retention signals controls surface expression of the T cell antigen receptor
por: Delgado, Pilar, et al.
Publicado: (2005)

Evaluation of determinants of the serological response to the quadrivalent split‐inactivated influenza vaccine
por: Wu, Shaohuan, et al.
Publicado: (2022)

Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes
por: Kon, Theone C., et al.
Publicado: (2016)

Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens
por: Jang, Hyesun, et al.
Publicado: (2018)

Surface modifications of influenza proteins upon virus inactivation by β-propiolactone*
por: She, Yi-Min, et al.
Publicado: (2013)

Novel Vaccines and Drugs That Target the Surface Glycoproteins of Influenza Viruses, RSV, Parainfluenza Viruses, and SARS-CoV-2
por: Russell, Charles J., et al.
Publicado: (2022)

Quantitative review of antibody response to inactivated seasonal influenza vaccines
por: Seidman, Jessica C., et al.
Publicado: (2011)

Novel strain of influenza virus is useful in inactivated vaccine production
Publicado: (1991)

Influenza: the virus and prophylaxis with inactivated influenza vaccine in “at risk” groups, including COPD patients
por: Hovden, Arnt-Ove, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_opipsagvb1mjkesdnlqn73o41q